Stifel highilghts these 2 stocks on news Bristol Myers will acqurie Karuna
Biotech analysts at Stifel highlight Neurocrine Biosciences (NASDAQ: NBIX) and ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
